Wolverine Asset Management’s Inozyme Pharma INZY Stock Holding History

Wolverine Asset Management’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-58,444	Closed	-$234K	–	1710
2025 Q2	$234K	Buy	+58,444	New	+$145K	﹤0.01%	1008

Wolverine Asset Management's INZY Position: Q3 2025 in Review

Wolverine Asset Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 58,444 shares — an estimated $234K sold.

Wolverine Asset Management first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $234K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Wolverine Asset Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Wolverine Asset Management sold 58,444 Inozyme Pharma shares in Q3 2025, an estimated $234K.
Wolverine Asset Management first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
Wolverine Asset Management's Inozyme Pharma position peaked at $234K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Wolverine Asset Management's 13F filing for Q3 2025, filed 28 Oct 2025.